Total Payments
$22,274
2024 Payments
$109.56
Companies
9
Transactions
34
Medicare Patients
1,735
Medicare Billing
$191,420
Payment Breakdown by Category
Consulting$9,615 (43.2%)
Other$8,980 (40.3%)
Travel$2,468 (11.1%)
Food & Beverage$1,123 (5.0%)
Education$88.90 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,615 | 5 | 43.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,980 | 3 | 40.3% |
| Travel and Lodging | $2,468 | 7 | 11.1% |
| Food and Beverage | $1,123 | 17 | 5.0% |
| Education | $88.90 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $11,685 | 15 | $0 (2021) |
| Eisai Inc. | $8,877 | 8 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,229 | 3 | $0 (2018) |
| Sirtex Medical Inc | $166.12 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $109.56 | 1 | $0 (2024) |
| Shire North American Group Inc | $104.71 | 1 | $0 (2018) |
| Mauna Kea Technologies, Inc. | $48.12 | 1 | $0 (2023) |
| FUJIFILM Healthcare Americas Corporation | $43.29 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $11.90 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.56 | 1 | AstraZeneca Pharmaceuticals LP ($109.56) |
| 2023 | $125.12 | 2 | Eisai Inc. ($77.00) |
| 2022 | $43.29 | 1 | FUJIFILM Healthcare Americas Corporation ($43.29) |
| 2021 | $4,560 | 2 | Eisai Inc. ($2,580) |
| 2019 | $8,316 | 9 | Exelixis Inc. ($4,443) |
| 2018 | $6,608 | 13 | Exelixis Inc. ($5,262) |
| 2017 | $2,512 | 6 | Eisai Inc. ($2,346) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $109.56 | General |
| 10/10/2023 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.12 | General |
| 08/18/2023 | Eisai Inc. | Lenvima (Drug) | Education | Cash or cash equivalent | $77.00 | General |
| Category: Oncology | ||||||
| 07/30/2022 | FUJIFILM Healthcare Americas Corporation | UTASWAKO AFP-L3 (Device) | Food and Beverage | In-kind items and services | $43.29 | General |
| Category: Medical Device | ||||||
| 12/16/2021 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Oncology | ||||||
| 11/18/2021 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,580.00 | General |
| Category: Oncology | ||||||
| 11/10/2019 | EISAI INC. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| Category: Oncology | ||||||
| 11/10/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $93.38 | General |
| Category: Oncology | ||||||
| 10/25/2019 | Exelixis Inc. | Cabometyx (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Oncology | ||||||
| 10/25/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $245.37 | General |
| Category: Oncology | ||||||
| 10/25/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $208.32 | General |
| Category: Oncology | ||||||
| 10/25/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Oncology | ||||||
| 10/25/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Oncology | ||||||
| 08/15/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $589.24 | General |
| Category: Oncology | ||||||
| 05/08/2019 | EISAI INC. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| Category: Oncology | ||||||
| 12/21/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Oncology | ||||||
| 11/27/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $104.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/10/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Oncology | ||||||
| 11/10/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $54.25 | General |
| Category: Oncology | ||||||
| 11/06/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Education | In-kind items and services | $11.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2018 | Exelixis Inc. | Cabometyx (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Oncology | ||||||
| 06/15/2018 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $870.10 | General |
| Category: Oncology | ||||||
| 06/15/2018 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $271.14 | General |
| Category: Oncology | ||||||
| 06/15/2018 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $254.59 | General |
| Category: Oncology | ||||||
| 06/15/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $81.13 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 387 | 501 | $230,795 | $40,701 |
| 2022 | 12 | 367 | 565 | $241,818 | $45,660 |
| 2021 | 13 | 441 | 658 | $275,157 | $58,018 |
| 2020 | 10 | 540 | 648 | $268,225 | $47,041 |
Total Patients
1,735
Total Services
2,372
Medicare Billing
$191,420
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 97 | $62,727 | $12,132 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 100 | $46,170 | $9,134 | 19.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 71 | $20,032 | $4,251 | 21.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 35 | $16,862 | $3,632 | 21.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 14 | 14 | $20,170 | $2,651 | 13.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $11,950 | $2,601 | 21.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 47 | $7,407 | $1,833 | 24.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 12 | 12 | $13,626 | $1,251 | 9.2% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 50 | 50 | $8,375 | $1,102 | 13.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,550 | $1,020 | 8.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $10,159 | $789.60 | 7.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 36 | $767.00 | $302.40 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 93 | 134 | $86,372 | $17,197 | 19.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 106 | $38,828 | $8,188 | 21.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 107 | $27,324 | $5,655 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 53 | $24,212 | $4,708 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $9,516 | $2,110 | 22.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $8,520 | $1,888 | 22.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $13,596 | $1,650 | 12.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $11,060 | $1,313 | 11.9% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 52 | 52 | $8,859 | $1,190 | 13.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $10,093 | $1,116 | 11.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $2,809 | $535.59 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 33 | 37 | $629.00 | $109.56 | 17.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 93 | 177 | $101,167 | $24,092 | 23.8% |
About Dr. Roniel Cabrera, MD
Dr. Roniel Cabrera, MD is a Gastroenterology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619901717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roniel Cabrera, MD has received a total of $22,274 in payments from pharmaceutical and medical device companies, with $109.56 received in 2024. These payments were reported across 34 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($9,615).
As a Medicare-enrolled provider, Cabrera has provided services to 1,735 Medicare beneficiaries, totaling 2,372 services with total Medicare billing of $191,420. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Gainesville, FL
- Active Since 07/11/2006
- Last Updated 03/14/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1619901717
Products in Payments
- Cabometyx (Drug) $9,705
- Lenvima (Drug) $8,877
- CABOMETYX (Drug) $1,980
- Stivarga (Drug) $1,229
- SIR-Spheres Microspheres (Device) $166.12
- GATTEX (Drug) $104.71
- UTASWAKO AFP-L3 (Device) $43.29
- XIFAXAN (Drug) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Gainesville
Charles Sninsky, Md, MD
Gastroenterology — Payments: $1.2M
Gastroenterology $1.2M
Peter Draganov, Md, MD
Gastroenterology — Payments: $1.1M
Gastroenterology $1.1M
Christopher Forsmark, Md, MD
Gastroenterology — Payments: $94,323
Gastroenterology $94,323
Ahmed Ouni
Gastroenterology — Payments: $31,897
Gastroenterology $31,897
Virginia Clark, Md, MD
Gastroenterology — Payments: $23,687
Gastroenterology $23,687
Dr. Justin Forde, M.d, M.D
Gastroenterology — Payments: $20,763
Gastroenterology $20,763